Paramethadione
From Wikipedia, the free encyclopedia
|
Paramethadione
|
|
| Systematic (IUPAC) name | |
| 5-ethyl-3,5-dimethyl-oxazolidine-2,4-dione | |
| Identifiers | |
| CAS number | |
| ATC code | N03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C7H11NO3 |
| Mol. mass | 157.167 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | Not significant |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
D(US) |
| Legal status | |
| Routes | ? |
Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.[1]
[edit] References
- ^ Multiple Congenital Anomaly/Mental Retardation (MCA/MR) Syndromes - Retrieved January 2007.
[edit] External links
- DDB 33106
- Hoffman, D; Chun A (1975). "Paramethadione and metabolite serum levels in humans after a single oral paramethadione dose". J Pharm Sci 64 (10): 1702–1703. doi:. PMID 1185541.

